ClinVar Miner

Submissions for variant NM_007078.3(LDB3):c.1472T>A (p.Val491Glu) (rs139709036)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section,National Institutes of Health RCV000171996 SCV000054756 uncertain significance not provided 2013-06-24 criteria provided, single submitter research
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000038731 SCV000062409 uncertain significance not specified 2012-04-11 criteria provided, single submitter clinical testing The Val491Glu variant (LDB3) has not been reported in the literature nor previou sly identified by our laboratory. Computational analyses (biochemical amino aci d properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Val 491Glu variant may impact the protein, though this information is not predictive enough to determine pathogenicity. This variant has been identified in 0.03% (1 /3738) of African American chromosomes from a broad population by the NHLBI Exom e Sequencing Project (; dbSNP rs139709036). In summary, additional information is needed to fully assess the clinical signific ance of the Val491Glu variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.